Skip to main content
. 2005 Jun 7;11(21):3250–3254. doi: 10.3748/wjg.v11.i21.3250

Table 3.

The comparison of UGT1A1 genotypes between case and control groups.

UGT1A1 genotype Case group (n = 268)
Control group (n = 441)
P2 test)
Number % Number %
Wild type 121 45.2 218 49.4 0.78
Heterozygous variation 118 44.0 186 42.23
6/71 37 96
211 G to A/normal 76 79
1091 C to T/normal 5 11
Compound heterozygous variation 23 8.6 34 7.7
6/7, 211 G to A/normal 13 6
6/7, 686 C to A/normal 8 20
6/7, 1091 C to T/normal 0 2
6/7, 211 G to A/normal, 1 2
686 C to A/normal 6/7,
686 C to A/normal, 1 0
1091 C to T/normal
211 G to A/normal, 0 4
1091 C to T/normal
Homozygous variation 6 2.2 3 0.7
7/72 1 0
211 G to A/211 G to A 4 3
7/7, 211 G to A/normal 1 0
1

6/7 and

2

7/7 represent A(TA)6TAA/A(TA)7TAA and A(TA)7TAA/A(TA)7TAA in the promoter area of UGT1A1 gene, respectively.

3

The expected frequency is 40.7% calculated by Hardy-Weinberg equilibrium: [2×(frequency of wild type)1/2×(frequency of compound heterozygous variation plus frequency of homozygous variation)1/2 = 2×49.41/2×(7.7+0.7)1/2 = 40.7]. The observed frequency (42.2%) is not significantly different from the expected frequency (40.7%) (P = 0.89 by χ2 test).